Oczakir Ceyda, Balmer Sacha, Mericske-Stern Regina
Department of Prosthodontics, University of Bern, Switzerland.
Int J Prosthodont. 2005 Sep-Oct;18(5):383-9.
The aim of the study was to assess implant survival and complications with implants and prostheses in patients exhibiting a variety of systemic diseases and congenital defects.
Patients with specific medical conditions are regularly treated at the Department of Prosthodontics, University of Bern, Switzerland. All those who had received implant-prosthodontic treatment during the past 12 years were reexamined for this study. Among these patients the following diseases were observed: cleft lip/palate (n = 8), Down syndrome (n = 3), Sjogren syndrome and scleroderma (n = 2), ectodermal dysplasia (n = 4), developmental retardation (n = 2), chronic leukemia (n = 2), lichen planus (n = 1), cerebral palsy (n = 1), deaf-muteness (n = 1), amyotrophic lateral sclerosis (n = 1). At the time of the treatment the mean age was 55.6 years. ITI implants had been placed according to a standard protocol with local anesthesia, except for one patient in whom full anesthesia was used. One hundred three implants were loaded and supported a total of 34 fixed or removable prostheses. All patients were appointed to a regular maintenance care program. In the context of the present study, all but 1 patient were reexamined clinically. New radiographs were obtained, and the implants and prostheses assessed. Additional information was obtained from regular records in the patients' charts.
Three implants were lost in the healing phase, and 1 implant was replaced. Only 1 patient with 4 implants was lost from the study (she had passed away). The survival rate of the loaded implants was 100%. In 1 patient, peri-implant bony defects were detected around all 3 intraforaminal implants. The prosthetic plan was maintained in all patients, and they continued to wear the originally planned type of prosthesis. Complications included insufficient hygiene, soft tissue hyperplasia, extraction of remaining teeth, and minor maintenance or repair of the prostheses.
So far, the mostly unknown implications and possible risks for the process of osseointegration and long-term maintenance in patients with such rare diseases and defects has resulted in a rather restricted application of implants. However, from the present results, it appears that implants can successfully be placed and maintained. This is ascribed in part to a strict maintenance care program provided by the caregivers and to a high compliance of the patients who participated in this program to perform good oral hygiene.
本研究旨在评估患有各种全身性疾病和先天性缺陷的患者植入物及修复体的植入物存活率和并发症情况。
患有特定疾病的患者在瑞士伯尔尼大学口腔修复科接受定期治疗。对过去12年中接受过种植修复治疗的所有患者进行重新检查以进行本研究。在这些患者中观察到以下疾病:唇腭裂(n = 8)、唐氏综合征(n = 3)、干燥综合征和硬皮病(n = 2)、外胚层发育不良(n = 4)、发育迟缓(n = 2)、慢性白血病(n = 2)、扁平苔藓(n = 1)、脑瘫(n = 1)、聋哑(n = 1)、肌萎缩侧索硬化症(n = 1)。治疗时平均年龄为55.6岁。除1例使用全身麻醉的患者外,ITI种植体均按照标准方案在局部麻醉下植入。共植入103枚种植体,支持34个固定或可摘修复体。所有患者均被纳入定期维护护理计划。在本研究中,除1例患者外,所有患者均接受了临床复查。拍摄了新的X光片,并对种植体和修复体进行了评估。从患者病历的常规记录中获取了其他信息。
愈合期有3枚种植体丢失,1枚种植体被替换。本研究中仅1例有4枚种植体的患者退出研究(她已去世)。植入种植体的存活率为100%。1例患者在所有3枚孔内种植体周围均检测到种植体周围骨缺损。所有患者的修复计划均得以维持,他们继续佩戴原计划类型的修复体。并发症包括口腔卫生不足、软组织增生、余留牙拔除以及修复体的 minor 维护或修复。
到目前为止,对于患有此类罕见疾病和缺陷的患者,骨结合过程和长期维护中大多未知的影响和潜在风险导致种植体的应用相当受限。然而,从目前的结果来看,种植体似乎可以成功植入并维持。这部分归因于护理人员提供的严格维护护理计划以及参与该计划的患者对保持良好口腔卫生的高度依从性。